Clinical Trials Browser

Phase 3 × Carcinoma, Squamous Cell × advexin × Clear all

NCT00041613 2008-04-01

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

Phase 3 Unknown

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell